Presidential Task Force on the Use of Unproven Cellular Therapies


The Presidential Task Force on the Use of Unproven Cellular Therapies strives to:

Identify key aspects of unproven cellular interventions in order to promote and share effective strategies between scientific/medical societies, health-care stakeholders, patient associations, and individuals, promoting the role of rigorous research and appropriate investigation and application of cell based therapies.

Learn more about Task Force Resources - Click here to view

Committee Chairs:

Massimo Dominici, MD
Chair (June 2016-2018)
University Hospital of Modena & Reggio Emilia - Modena Policlinic
Modena, Italy
Vice - Chair (June 2016-2018)
Royal Prince Alfred Hospital
Sydney, Australia 

Mickey Koh,MD, PhD, FRCP, FRCPath
Vice - Chair (June 2016-2018)
St George University Hospital
London, United Kingdom & Singapore, Singapore

Daniel J. Weiss, MD, PhD
Vice - Chair (June 2016-2018)
University of Vermont
Burlington, VT, United States
Aaron Levine, PhD, MPhil
Vice - Chair (June 2016-2018)
Georgia Tech
Atlanta, GA, United States 
Karen Nichols, Esq.
Vice - Chair (June 2016-2018)

Magenta Therapeutics

Cambridge, MA, United States 

Committee Members: 

Catherine Bollard, MBChB, MD
Children's National Health System and The George Washington University
Washington, DC, United States
Bianca Buechner, PhD, LLM
Alexion Pharmaceuticals Inc.
Zürich Area, Switzerland
Sarah Chan, MA, PhD
The University of Edinburgh
Edinburgh, Scotland, United Kingdom 
Natividad Cuende, MD, MPH, PhD
Andalusian Initiative for Advanced Therapies
Sevilla, Spain
Miguel Forte, MD, PhD
Zelluna Immunotherapy
Oslo, Norway
Kurt Gunter, MD, FASCP
Cell Medica
Houston, TX, United States

Megan Munsie, PhD
Stem Cells Australia
Melbourne, Australia 
Lynn O'Donnell, PhD
Ohio State University, James Cancer Hospital
Columbus, OH, USA 
Alok Srivastava, MBBS, MD, FRACP, FRCPA, FRCP
Christian Medical College
Vellore, India
Leigh Turner, PhD
University of Minnesota

Minneapolis, MN, United States 
Dominic Wall, PhD, FFSc (RCPA)
Peter MacCallum Cancer Center
East Melbourne, VIC, Australia 
Claudio J. Zurlo, MD
Sciclone Pharmaceuticals Int Ltd.
Buenos Aires, Argentina
Laertis Ikonomou, PhD
Boston University Boston, MA, United States




© 2018 ISCT. All rights reserved. 
ISCT, and the ISCT logo are registered service marks of the International Society for Cellular Therapy.
The BEACON and lighthouse logo is a service mark of the International Society for Cellular Therapy.